Navigation Links
maxIT Healthcare Named to Inc. 5000 List
Date:8/26/2010

WESTFIELD, Ind., Aug. 26 /PRNewswire/ -- maxIT Healthcare, a leading professional consulting services company for healthcare providers, has been recognized by Inc. magazine on its third annual Inc. 5000 list of the nation's fastest growing private companies. With three year sales growth of over 59%, maxIT was ranked number 3264 on the list. This is the second consecutive year that maxIT has made the list.

"We are excited to be named to the Inc. 5000 list again," said Parker Hinshaw, CEO and Founder of maxIT. "Our growth and success over the past few years are the result of the focus, flexibility and hard work of our consultants and leadership team during a very challenging economic period. I'm proud of our team for their passion and commitment to helping healthcare organizations improve quality of care and patient safety through information technology."

maxIT provides critical IT support that helps healthcare organizations improve their clinical, financial, operational and IT outcomes. With over 430 senior consultants, maxIT offers implementation, project management, and management consulting expertise in healthcare information systems (HIS), electronic medical record (EMR) systems, enterprise resource planning (ERP) systems, payer systems, and clinical imaging and informatics systems (for radiology and cardiology).

The 2010 Inc. 5000 is ranked according to percentage revenue growth from 2006 through 2009. To qualify, companies must have been founded and generating revenue prior to 2006; must be U.S.-based, privately held, for profit, and independent as of December 31, 2009; and must have revenue in 2009 of at least $2 million. The top 10 percent of companies on the list comprise the Inc. 500, now in its 28th year. For more information about the Inc. 5000, visit www.inc.com.

About maxIT Healthcare, LLC

maxIT Healthcare has been completely focused on Healthcare Infor
'/>"/>

SOURCE maxIT Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Healthcare Network Helps Fund Scholarships Totaling $15,000
2. Scott & White Healthcare President and CEO Alfred B. Knight, M.D. to Retire in 2011, Will Lead Foundation
3. Lialda(R) - Shire Files Suit Against Cadila Healthcare Limited, Doing Business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.
4. CBR Pharma Insights' Latest Report, The New Era of Healthcare Reform - Supporting Revenue Growth through Understanding & Adaptation
5. Medical Simulation Corporation Partners with Hutchinson Technology in Training of Healthcare Professionals on Noninvasive Tissue Oxygenation Monitoring
6. Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life
7. Healthcare Data Solutions Announces New Service, PrescriberPRO Rx
8. Accuray Incorporated to Speak at Wells Fargo Securities Healthcare Conference
9. Lexicon to Present at Two Major Healthcare Investor Conferences
10. Omeros To Webcast Presentation at Ninth Annual Needham Healthcare Conference
11. OncoGenex Pharmaceuticals to Present at the 9th Annual Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2012)... AUSTIN, Texas, May 15, 2012 Vermillion, Inc. ... company, reported financial and operational results for the first ... Operational Highlights , In Q1, the volume ... help differentiate benign from malignant ovarian masses, was generally ... the quarter and demonstrated an increase of 28% to ...
(Date:5/15/2012)... 2012 Reportlinker.com announces that ... available in its catalogue: , ... and Market Forecast to 2019 ... Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment ... Summary GlobalData, the industry analysis ...
(Date:5/15/2012)... May 15, 2012 Generex Biotechnology Corporation (OTCBB: ... pivotal Phase III trials, is pleased to announce today ... of its wholly-owned subsidiary, Antigen Express, Inc., has been ... in clinical trial research and immuno-therapeutic treatments of breast ... Indiana University School of Medicine ...
(Date:5/15/2012)... BGI, one of the world,s ... GS FLX+ System has been successfully installed at its ... the existing array of short read sequencing technologies and ... GS FLX+ System, developed by 454 Life Sciences, a ... exceptional accuracy and high-throughput, making the system well suited ...
Breaking Biology Technology:Vermillion Reports First Quarter 2012 Results 2Vermillion Reports First Quarter 2012 Results 3Vermillion Reports First Quarter 2012 Results 4Vermillion Reports First Quarter 2012 Results 5Vermillion Reports First Quarter 2012 Results 6Vermillion Reports First Quarter 2012 Results 7Vermillion Reports First Quarter 2012 Results 8Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019 2Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019 3Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019 4Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019 5Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019 6Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019 7Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019 8Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019 9Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019 10Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers 2Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers 3Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers 4BGI Installs Roche GS FLX+ System to Enhance Long Read Sequencing Capabilities for Genome and Transcriptome Research 2BGI Installs Roche GS FLX+ System to Enhance Long Read Sequencing Capabilities for Genome and Transcriptome Research 3
... April 30 Tigris Pharmaceuticals, Inc., a privately held ... on its novel molecule, AFP-464, during the recent AACR ... represents a significant advancement in the treatment of Triple ... of invasive breast cancer," stated Edmundo Muniz, M.D., Ph.D., ...
... Educational Webinar "How Organizations Can Make the Transition to ... Virtify, Inc. , , CAMBRIDGE, Mass., April ... the market leader in Enterprise Content Compliance solutions for ... ), a provider of Enterprise Compliance and Quality Management ...
... 30 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ... for the first quarter ended March 31, 2009. , ... first quarter in what has been a difficult business ... and CEO of Angiotech. "Sales in our proprietary Surgical ...
Other Biology Technology:Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 2Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 3Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 4Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes' 2Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes' 3Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 2Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 3Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 4Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 5Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 6Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 7Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 8Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 9Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 10Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 11Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 12Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 13Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 14Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 15Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 16Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 17Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 18Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 19Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 20Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 21
(Date:5/21/2012)... Institution (WHOI) have conducted a new study to measure ... Ocean. The study, recently published in the journal ... understand the Arctic Ocean,s carbon cyclethe pathway through which ... It will also offer an important point of reference ... time, and how the ecosystem responds to rising global ...
(Date:5/21/2012)... Woesik, Florida Institute of Technology professor of biological ... the National Science Foundation for research into the ... develop quantitative approaches to assess the clustering of ... the corals. When diseases cluster they are usually ... cause of infection., Although diseases are one of ...
(Date:5/21/2012)... the National University of Singapore,s (NUS) Department of Biological ... compound a compound that is undergoing preclinical trials ... of energy and stop them from growing into a ... This is the first time a research group has ... formation. , Building on the new findings, the ...
Breaking Biology News(10 mins):New study by WHOI scientists provides baseline measurements of carbon in Arctic Ocean 2New study by WHOI scientists provides baseline measurements of carbon in Arctic Ocean 3Novel discovery by NUS scientists paves the way for more effective treatment of cancers 2Many Parents in the Dark About Drug Resistant Infections 3A Study 76703 1Many Parents in the Dark About Drug Resistant Infections 3A Study 76703 2Former FDA Inspectors Train Medical Device Pharmaceutical Companies How to Comply with Latest FDA Expectations for Validation and Part 11 17786 1Former FDA Inspectors Train Medical Device Pharmaceutical Companies How to Comply with Latest FDA Expectations for Validation and Part 11 17786 2Regenicin to Present Live at RetailInvestorConferences com on November 4th 17784 1Regenicin to Present Live at RetailInvestorConferences com on November 4th 17784 2
... requires many years of growth before a tree is ready ... Now, scientists at universities in Sweden and the United States ... , In the annual plant Arabidopsis, the first plant to ... Locus T (FT) induce flowering in response to day length. ...
... ants, most people prefer to wipe the venomous little varmints off ... own back yards. The reviled South American native that invaded the ... circles as Solenopsis invicta and everywhere else as a painful pest ... Tschinkel. , An ardent fire ant fan and one of its ...
... a lawnmower, the Holy Grail of horticultural accomplishment would be ... Now, that vision of suburban bliss -- and more -- ... pathway that regulates the stature of plants. In addition to ... the development of sturdier, more fruitful crop plants such as ...
Other Biology News:Scientists discover that ancient genes dictate flowering, fall bud set 2Fire ants: Their true story told by the scientist who loves them 2Fire ants: Their true story told by the scientist who loves them 3No-mow grass may be coming to your yard soon 2No-mow grass may be coming to your yard soon 3
...
...
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
Chicken polyclonal to QPRT ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to Internal sequence amino acids 123-237 of Human QPRT Entrez Gene ID: 23475 ...
Biology Products: